SCHEMBL21387743

SCHEMBL21387743

O=C(S)NCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 2/20 0.59
▸ HDAC1 Q13547 2/20 0.59
▸ HDAC2 Q92769 2/20 0.59
▸ HDAC6 Q9UBN7 2/20 0.59
▸ HDAC10 Q969S8 1/20 0.59
▸ HDAC11 Q96DB2 1/20 0.59
▸ HDAC8 Q9BY41 1/20 0.59
▸ MTOR P42345 2/20 0.56
▸ LSS P48449 1/20 0.55
▸ NAMPT P43490 1/20 0.53
▸ MAPK14 Q16539 1/20 0.52
▸ EPHX2 P34913 2/20 0.49
▸ PPARG P37231 2/20 0.49
▸ PPARA Q07869 1/20 0.49
▸ FFAR1 O14842 1/20 0.49
▸ P2RX7 Q99572 2/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA7 P43166 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24575984 0.85 MTOR (0.69) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL1695141 0.83 MTOR (0.58) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL3897948 0.81 CYP2C9 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL4881592 0.81 EPHX2 (0.61) HDAC3HDAC6HDAC8EPHX2MEN1
SCHEMBL2629356 0.81 LSS (0.59) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL4576236 0.79 MTOR (0.54) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL3417449 0.79 LSS (0.56) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL10594986 0.79 HDAC3 (0.60) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL934145 0.79 HDAC3 (0.60) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL5347157 0.78 HDAC3 (0.55) HDAC3HDAC1HDAC2HDAC6HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 — — EP disclosed
Send feedback